Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Sponsor

Memorial Sloan Kettering Cancer Center (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT00580203

Collaborator

American Cancer Society, Inc. (Other)

1,307

Enrollment

Location

226

Duration (Months)

5.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.

Condition or Disease	Intervention/Treatment	Phase
Head and Neck Cancers

Detailed Description

Study Design

Study Type:

Observational

Anticipated Enrollment :

1307 participants

Observational Model:

Case-Only

Time Perspective:

Prospective

Official Title:

Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Study Start Date :

Feb 1, 2004

Anticipated Primary Completion Date :

Dec 1, 2022

Anticipated Study Completion Date :

Dec 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
1 Patients with head and neck cancers

Outcome Measures

Primary Outcome Measures

Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future. [36 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes.
Patients will be entered onto this protocol without preference for any racial or ethnic group.
Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy.
The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded.